好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Disruptive Sleep in Developmental and Epileptic Encephalopathies: Interim Results of a Caregiver Survey
Epilepsy/Clinical Neurophysiology (EEG)
P4 - Poster Session 4 (8:00 AM-9:00 AM)
11-002

To define typical and disruptive sleep patterns in patients with developmental and epileptic encephalopathies (DEEs) and explore their association with activities of daily living (ADLs) and communication.

DEEs are characterized by high seizure burden and developmental disability. Sleep disruptions are common in people with DEE. Caregiver definitions of typical (“normal”) and disruptive sleep, and caregiver observations of their effects on ADLs (feeding, bathing/hygiene, dressing, and toileting) and communication, have not been extensively explored.

An anonymous, internet-based, 63-question survey, developed in consultation with the Dravet Syndrome Foundation and Lennox-Gastaut Syndrome Foundation, was distributed to caregivers of patients with DEEs via DEE-specific communities (March 11–April 30, 2024). Data specific to disruptive sleep patterns and their impact on ADLs and communication were assessed.

Of 489 caregivers (median patient age [range], years: 8 [0–67]), sleep was “unpredictable with no typical pattern” in 47 (9.6%) patients. Daily disruptive sleep was experienced by 132 (27.0%) patients. Medical device and medication side effects were reported as factors in excessive sleep in 11 (2.2%) and 164 (33.5%) patients, respectively.

Most caregivers reported a “good night of sleep” for the patient as a sleep duration of 5–7 (n=126, 25.8%) or 7+ hours (n=314, 64.2%). Approximately half of caregivers reported co-sleeping with the patient (n=223, 45.6%) and use of a nighttime seizure-monitoring device (n=250, 51.1%); 97 (19.8%) reported both co-sleeping and use of a seizure-monitoring device. Alarms without observed seizure activity occurred for 112/250 (44.8%) using a device.

Sleep disruptions were associated with the temporary loss of ≥1 ADL in 120 (24.5%) patients and temporary loss of communication in 105 (21.5%) patients.

Sleep disturbances in approximately a quarter of patients with DEE were associated with temporary loss of an ADL or communication. Further analyses on relationships among DEEs, disruptive sleep, and quality of life are warranted.

Authors/Disclosures
Andrea L. Wilkinson, BA
PRESENTER
Ms. Wilkinson has received personal compensation for serving as an employee of UCB. Ms. Wilkinson has or had stock in UCB.
David Bearden, MD (University of Rochester School of Medicine) Dr. Bearden has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bearden has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Bearden has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for law firms.
Brad Bryan, PhD Dr. Bryan has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant with KCNT1 Epilepsy Foundation. Dr. Bryan has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant with FamilieSCN2A Foundation. Dr. Bryan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with CAMK2 Therapeutics Network. An immediate family member of Dr. Bryan has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant with Global Dare. An immediate family member of Dr. Bryan has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant with CAMK2 Therapeutics Network.
Eileen Devine Mrs. Devine has nothing to disclose.
Amber freed Mrs. freed has received personal compensation for serving as an employee of SLC6A1 Connect. Mrs. freed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cure GABA A. Mrs. freed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Foundation for USP7 Disorders. Mrs. freed has received personal compensation in the range of $100,000-$499,999 for serving as a Founder with SLC6A1 Connect.
John Michael GRAGLIA An immediate family member of Mr. GRAGLIA has received personal compensation for serving as an employee of Francisco Partners. Mr. GRAGLIA has stock in BBIO. Mr. GRAGLIA has stock in BMRN. Mr. GRAGLIA has stock in CAMP. Mr. GRAGLIA has stock in NVS. Mr. GRAGLIA has stock in PRAX. Mr. GRAGLIA has stock in RARE. Mr. GRAGLIA has stock in RGNX. Mr. GRAGLIA has stock in STOK.
Amelie Lothe, PhD Dr. Lothe has received personal compensation for serving as an employee of UCB. Dr. Lothe has stock in UCB.
Michelle Manzo (UCB) Ms. Manzo has received personal compensation for serving as an employee of UCB Pharma. Ms. Manzo has stock in UCB Pharma.
Mercedes F. Martin, NP Mrs. Martin has received personal compensation for serving as an employee of UCB.
Mary Anne Meskis, N/A Mrs. Meskis has received personal compensation in the range of $100,000-$499,999 for serving as a Executive Director with Dravet Syndrome Foundation.
Charlene Son S. Rigby, MBA Ms. Rigby has received personal compensation for serving as an employee of Global Genes. Ms. Rigby has stock in AlphaRose.
Jo Sourbron, MD, PhD, MPharm Dr. Sourbron has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Sourbron has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bright Minds Biosciences.
Karen Utley, RN, BSN, RN Ms. Utley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ultragenyx. Ms. Utley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medable. Ms. Utley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Longboard Pharmaceuticals. Ms. Utley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB.
Laurie M. Bailey, BCPA Ms. Bailey has received personal compensation for serving as an employee of UCB, Inc.. Ms. Bailey has stock in UCB, Inc..